Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09892 | 31572482 | Arch Med Sci | Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease. | 2019 | Details |
| A09919 | 31560040 | Inflamm Bowel Dis | Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD. | 2019 | Details |
| A09923 | 31558861 | World J Gastroenterol | Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways. | 2019 | Details |
| A09938 | 31553803 | Hepatology | Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort. | 2020 | Details |
| A09953 | 31545133 | Metab Syndr Relat Disord | Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals. | 2019 | Details |
| A09966 | 31541796 | Phytomedicine | Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs. | 2019 | Details |
| A09969 | 31540903 | Diabetes Care | Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial. | 2019 | Details |
| A09972 | 31539884 | J Physiol Pharmacol | Diverse inhibition of forkhead box O1 activity by linoleic acid isomers - potential role in lipid metabolism in HepG2 cells and livers of C57BL/6J mice. | 2019 | Details |
| A09984 | 31536600 | PLoS One | Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes. | 2019 | Details |
| A09992 | 31533345 | Medicina (Kaunas) | Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients. | 2019 | Details |
| A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
| A10021 | 31521875 | Eur J Radiol | MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10036 | 31517837 | Medicine (Baltimore) | Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer. | 2019 | Details |
| A10045 | 31515740 | Hepatol Int | Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. | 2019 | Details |
| A10048 | 31514105 | Cytokine | Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2019 | Details |
| A10056 | 31506976 | Hepatology | Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. | 2020 | Details |
| A10060 | 31505802 | Nutrients | Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models. | 2019 | Details |
| A10064 | 31505261 | Biochim Biophys Acta Mol Cell Biol Lipids | Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures. | 2019 | Details |
| A10075 | 31499676 | Math Biosci Eng | Quantitative analysis of non-alcoholic fatty liver in rats via combining multiple ultrasound parameters. | 2019 | Details |
| A10084 | 31494259 | Alcohol | Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH) and normal controls. | 2019 | Details |
| A10086 | 31493428 | Hum Pathol | Pathology of liver disease: advances in the last 50 years. | 2019 | Details |
| A10087 | 31493247 | Hormones (Athens) | Selenium and selenoprotein P in nonalcoholic fatty liver disease. | 2019 | Details |
| A10091 | 31491605 | Ecotoxicol Environ Saf | Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells. | 2019 | Details |
| A10100 | 31484207 | J Periodontol | Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. | 2019 | Details |
| A10119 | 31475226 | Endosc Int Open | EUS-guided gallbladder drainage in patients with cirrhosis: results of a multicenter retrospective study. | 2019 | Details |
| A10127 | 31474630 | Yakugaku Zasshi | [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management]. | 2019 | Details |
| A10129 | 31473923 | Environ Sci Pollut Res Int | Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents. | 2019 | Details |
| A10141 | 31470620 | Molecules | Study of Methionine Choline Deficient Diet-Induced Steatosis in Mice Using Endogenous Fluorescence Spectroscopy. | 2019 | Details |
| A10146 | 31470068 | J Hepatol | The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. | 2019 | Details |
| A10152 | 31467308 | Sci Rep | High-fat and high-cholesterol diet decreases phosphorylated inositol-requiring kinase-1 and inhibits autophagy process in rat liver. | 2019 | Details |
| A10155 | 31465774 | Biochem Pharmacol | Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10164 | 31463596 | Surg Today | Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. | 2019 | Details |
| A10178 | 31449538 | PLoS One | Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. | 2019 | Details |
| A10184 | 31445117 | Magn Reson Imaging | Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit model. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10198 | 31437454 | Gastrointest Endosc | EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: a prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease. | 2019 | Details |
| A10200 | 31436905 | Cancer Med | The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance. | 2019 | Details |
| A10207 | 31433166 | Biochemistry | A Panel of Protein Kinase Chemosensors Distinguishes Different Types of Fatty Liver Disease. | 2019 | Details |
| A10232 | 31419516 | Pharmacol Ther | The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease. | 2019 | Details |
| A10256 | 31409057 | Cells | iPla2β Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation. | 2019 | Details |
| A10289 | 31398386 | J Am Coll Surg | Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. | 2019 | Details |
| A10297 | 31394020 | Am J Transplant | The decreasing predictive power of MELD in an era of changing etiology of liver disease. | 2019 | Details |
| A10302 | 31393374 | Medicine (Baltimore) | Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease. | 2019 | Details |
| A10306 | 31391765 | World J Gastroenterol | Importance of fatigue and its measurement in chronic liver disease. | 2019 | Details |
| A10307 | 31391764 | World J Gastroenterol | Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. | 2019 | Details |
| A10318 | 31388627 | Hepatol Commun | Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2019 | Details |
| A10356 | 31377187 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease? | 2019 | Details |
| A10370 | 31371265 | Nutr Metab Cardiovasc Dis | Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. | 2019 | Details |
| A10371 | 31369716 | J Dent Res | Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. | 2019 | Details |
| A10374 | 31366982 | Sci Rep | Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. | 2019 | Details |
| A10392 | 31357780 | Zhonghua Gan Zang Bing Za Zhi | [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis]. | 2019 | Details |
| A10400 | 31354322 | Diabetes Metab Syndr Obes | Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women. | 2019 | Details |
| A10414 | 31345776 | Lancet Diabetes Endocrinol | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. | 2019 | Details |
| A10420 | 31343116 | Obesity (Silver Spring) | Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis. | 2019 | Details |
| A10427 | 31341422 | Mediators Inflamm | Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10477 | 31320150 | Ultrasound Med Biol | Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10483 | 31317132 | EClinicalMedicine | Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians. | 2019 | Details |
| A10495 | 31311491 | BMC Gastroenterol | Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. | 2019 | Details |
| A10501 | 31310032 | J Gastroenterol Hepatol | Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease. | 2019 | Details |
| A10505 | 31309589 | Hepatology | Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. | 2019 | Details |
| A10514 | 31307592 | Adv Pharmacol | Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. | 2019 | Details |
| A10517 | 31305280 | J Clin Gastroenterol | CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness. | 2020 | Details |
| A10545 | 31293441 | Front Physiol | The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10547 | 31293337 | World J Gastroenterol | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A10574 | 31283861 | Oral Dis | Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways. | 2019 | Details |
| A10582 | 31280650 | Organogenesis | Ectopic localization of autophagosome in fatty liver is a key factor for liver regeneration. | 2019 | Details |
| A10596 | 31277096 | Medicine (Baltimore) | The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: An observational Study. | 2019 | Details |
| A10597 | 31275587 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study. | 2019 | Details |
| A10609 | 31272248 | Scand J Gastroenterol | Transient liver elastography in normal pregnancy - a longitudinal cohort study. | 2019 | Details |
| A10613 | 31271665 | Hepatology | Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. | 2019 | Details |
| A10623 | 31266893 | Proc Natl Acad Sci U S A | p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity. | 2019 | Details |
| A10635 | 31260574 | J Eur Acad Dermatol Venereol | High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. | 2019 | Details |
| A10640 | 31258138 | Turk J Gastroenterol | Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. | 2019 | Details |
| A10641 | 31258135 | Turk J Gastroenterol | Non-alcoholic fatty liver disease: A growing public health problem in Turkey. | 2019 | Details |
| A10643 | 31256692 | J Diet Suppl | The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2019 | Details |
| A10647 | 31255652 | Gastroenterology | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10653 | 31252266 | Biomed Pharmacother | Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |
| A10675 | 31241693 | Rev Paul Pediatr | PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS. | 2019 | Details |
| A10734 | 31216433 | J Ethnopharmacol | Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. | 2019 | Details |
| A10737 | 31215394 | Mol Med | FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. | 2019 | Details |
| A10752 | 31209928 | J Hum Nutr Diet | Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease. | 2019 | Details |
| A10753 | 31209721 | Dig Dis Sci | Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. | 2019 | Details |
| A10760 | 31206765 | Echocardiography | Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography. | 2019 | Details |
| A10784 | 31195161 | Clin Gastroenterol Hepatol | Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis. | 2019 | Details |
| A10795 | 31189495 | Clin Nutr | Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. | 2019 | Details |
| A10800 | 31185686 | Nutrients | A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO). | 2019 | Details |
| A10805 | 31181878 | Korean J Intern Med | Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign. | 2019 | Details |
| A10821 | 31173462 | Cytometry B Clin Cytom | A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide Images. | 2019 | Details |
| A10823 | 31173180 | Int J Mol Med | Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin. | 2019 | Details |
| A10824 | 32812939 | Metabol Open | Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10840 | 31163617 | Int J Mol Sci | Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. | 2019 | Details |
| A10858 | 31153607 | Med Clin (Barc) | Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. | 2019 | Details |
| A10860 | 31152791 | Free Radic Biol Med | Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10885 | 31141073 | Arq Gastroenterol | 18F-FDG PET/CT AS AN ASSESSMENT TOOL OF HEPATOCELLULAR CARCINOMA SECONDARY TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN EXPERIMENTAL MODEL. | 2019 | Details |
| A10886 | 31140156 | Hormones (Athens) | Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease. | 2019 | Details |
| A10891 | 31137547 | Medicina (Kaunas) | Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10912 | 31128886 | J Pediatr | The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease. | 2019 | Details |
| A10942 | 31112805 | J Glob Antimicrob Resist | Refractory Helicobacter pylori gastritis: The hidden predictors of resistance. | 2019 | Details |